Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.KVK-Tech has given license to market and distribute rights of ANDA filing of dexbrompheniramine maleate 6mg/pseudoephedrine sulfate 120mg extended release tablets to Hi-Tech Pharmacal.
Subscribe to our email newsletter
Under the deal, the product will be marketed under Lodrane brand name by Hi-Tech’s branded sales and marketing company, ECR.
Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products.
Hi-Tech president and CEO David Seltzer said the product is similar to their Lodrane brand products and will allow them to leverage equity in the brand, particularly as approximately 500 unapproved cough/cold and allergy products will be removed from the market in September 2011.